123 related articles for article (PubMed ID: 34216791)
1. Different Kinetics and Risk Factors for Isolated Extramedullary Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia.
Hazar V; Öztürk G; Yalçın K; Uygun V; Aksoylar S; Küpesiz A; Ok Bozkaya İ; Karagün BŞ; Bozkurt C; İleri T; Atay D; Koçak Ü; Karasu GT; Yeşilipek A; Gökçe M; Kansoy S; Kintrup GT; Karakükcü M; Okur FV; Ertem M; Kaya Z; Gürsel O; Yaman Y; Özbek N; Antmen B; Tüfekçi Ö; Albayrak C; Adaklı Aksoy B; Sezgin G; Albayrak D; Evim MS; Zengin E; Pekpak E;
Transplant Cell Ther; 2021 Oct; 27(10):859.e1-859.e10. PubMed ID: 34216791
[TBL] [Abstract][Full Text] [Related]
2. Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.
Shem-Tov N; Saraceni F; Danylesko I; Shouval R; Yerushalmi R; Nagler A; Shimoni A
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1087-1094. PubMed ID: 28396161
[TBL] [Abstract][Full Text] [Related]
3. Acute Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The Good, the Bad, and the Ugly of Isolated Extramedullary Relapse in a Latin American Population.
Arias-Espinosa L; Acosta-Medina AA; Vargas-España A; Fuentes-Martin V; Colunga-Pedraza PR; Hawing-Zarate JA; Leon AG; Soto-Mota A; Pacheco-Gutierrez G; Vargas-Serafín C; Barrera-Lumbreras G; Bourlon C
Transplant Cell Ther; 2023 Aug; 29(8):510.e1-510.e9. PubMed ID: 37169289
[TBL] [Abstract][Full Text] [Related]
4. Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Gavriilaki M; Apostolou C; Iskas M; Voutiadou G; Bouziana S; Bousiou Z; Constantinou V; Masmanidou M; Sotiropoulos D; Yannaki E; Lalayanni C; Pilavaki M; Chatziioannou K; Papayannopoulos S; Anagnostopoulos A
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1756-1760. PubMed ID: 31128329
[TBL] [Abstract][Full Text] [Related]
5. Isolated Extramedullary Relapse After Human Leukocyte Antigen-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Case Reports and Literature Review.
Khemaphiphat P; Wudhikarn K; Bunworasate U; Chanswangphuwana C
Transplant Proc; 2021; 53(6):2029-2034. PubMed ID: 33962773
[TBL] [Abstract][Full Text] [Related]
6. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.
Solh M; DeFor TE; Weisdorf DJ; Kaufman DS
Biol Blood Marrow Transplant; 2012 Jan; 18(1):106-12. PubMed ID: 21703975
[TBL] [Abstract][Full Text] [Related]
7. Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.
Ando T; Mitani N; Matsunaga K; Nakazora T; Gondo T; Yujiri T; Tanizawa Y
Tohoku J Exp Med; 2010 Feb; 220(2):121-6. PubMed ID: 20139663
[TBL] [Abstract][Full Text] [Related]
8. Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?
Curley C; Durrant S; Kennedy GA
Asia Pac J Clin Oncol; 2013 Sep; 9(3):285-9. PubMed ID: 23418909
[TBL] [Abstract][Full Text] [Related]
9. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary relapse of leukemia after allogeneic hematopoietic stem cell transplantation: A retrospective study.
Xie N; Zhou J; Zhang Y; Yu F; Song Y
Medicine (Baltimore); 2019 May; 98(19):e15584. PubMed ID: 31083240
[TBL] [Abstract][Full Text] [Related]
11. Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes.
Mo XD; Kong J; Zhao T; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2023-8. PubMed ID: 25196855
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia.
Yu J; Ge X; Luo Y; Shi J; Tan Y; Lai X; Zhao Y; Ye Y; Zhu Y; Zheng W; Huang H
Ann Hematol; 2020 Nov; 99(11):2639-2648. PubMed ID: 32889611
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
Harris AC; Kitko CL; Couriel DR; Braun TM; Choi SW; Magenau J; Mineishi S; Pawarode A; Yanik G; Levine JE
Haematologica; 2013 Feb; 98(2):179-84. PubMed ID: 23065502
[TBL] [Abstract][Full Text] [Related]
14. Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Yuda S; Fuji S; Onishi A; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1152-1157. PubMed ID: 30660773
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemia].
Zu YL; Zhou J; Zhang Y; Fu YW; Fang BJ; Yu FK; Zhao HF; Gui RR; Liu YY; Li Z; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2021 Jan; 60(1):41-44. PubMed ID: 33397020
[No Abstract] [Full Text] [Related]
18. Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia.
Hazar V; Tezcan Karasu G; Öztürk G; Küpesiz A; Aksoylar S; Özbek N; Uygun V; İleri T; Okur FV; Koçak Ü; Kılıç SÇ; Akçay A; Güler E; Kansoy S; Karakükcü M; Bayram İ; Aksu T; Yeşilipek A; Karagün BŞ; Yılmaz Ş; Ertem M; Uçkan D; Fışgın T; Gürsel O; Yaman Y; Bozkurt C; Gökçe M;
Pediatr Transplant; 2021 Aug; 25(5):e13942. PubMed ID: 33320995
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children.
Gabelli M; Zecca M; Messina C; Carraro E; Buldini B; Rovelli AM; Fagioli F; Bertaina A; Lanino E; Favre C; Rabusin M; Prete A; Ripaldi M; Barberi W; Porta F; Caniglia M; Santarone S; D'Angelo P; Basso G; Locatelli F
Bone Marrow Transplant; 2019 Feb; 54(2):275-283. PubMed ID: 29899572
[TBL] [Abstract][Full Text] [Related]
20. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
